The First Medical Device to Receive National Biotechnology and Medical Care Quality Award - Silver Award: APrevent achieves a New Milestone!

經濟日報 劉美恩 https://money.udn.com/money/story/5724/8503264

APrevent proudly announces that its flagship product, VOIS Implant, has been honored with the 2024 Biotechnology and Medical Care Quality Award - Silver Award. This prestigious recognition highlights the company’s commitment to advancing patient care through groundbreaking medical technologies.

The SNQ National Biotechnology and Medical Care Quality Award are conferred annually by the Institute for Biotechnology and Medicine Industry (IBMI), under the auspices of the Taiwan government, to celebrate outstanding products that demonstrate excellence in quality, innovation, and safety. VOIS Implant’s success in securing the Silver Award underscores its exceptional design and remarkable clinical value.

“Receiving the National Quality Silver Award for VOIS Implant is an incredible honor for our entire team,” said Mark Chang, COO of APrevent. “This achievement reflects our unwavering dedication to improving patient outcomes through cutting-edge research, stringent quality standards, and close collaboration with medical professionals.”

APrevent continues to invest in research, development, and global partnerships to enhance the performance of VOIS Implant and expand its availability worldwide. The company’s strategic focus on patient safety and treatment effectiveness has paved the way for further innovation in the field of implantable medical devices.